Shifting how the world thinks about innovation in medicine.
With a holistic approach to oncology and autoimmune disease, Ichnos Sciences strives to make great leaps forward in the understanding of disease—the kind that lead to new answers and life-changing therapies. It’s how we’re shifting medicine forward.
- 03/21/2023 | Press Release
- Ichnos Sciences Receives Orphan Drug Designation for First-In-Class Bispecific (CD38 x CD47) Antibody Innate Cell Modulator, ISB 1442. Read more
- 02/09/2023 | Corporate Update
- February 2023 Update
. Read more - 12/12/2022 | Press Release
- Ichnos Sciences Presents Data Supporting Three Oncology Assets at ASH 2022 Annual Meeting. Read more
Write a new chapter in medicine
Start-up spirit. Experienced leadership. A mission of change. Forging a new path that pursues disease holistically, Ichnos Sciences brings the courage and passion to take scientific risks and pursue the greatest of challenges. To give physicians and patients not just hope but progress.
View Career Opportunities
The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.
